Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06419595 |
Other study ID # |
Exploratory 1 |
Secondary ID |
PAR-24-210 |
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 1, 2025 |
Est. completion date |
March 31, 2027 |
Study information
Verified date |
May 2024 |
Source |
Cambridge Health Alliance |
Contact |
Laura Podewils, PhD |
Phone |
303-436-6000 |
Email |
laura.podewils[@]dhha.org |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
To adapt the Screening and Support for Youth (SASY) intervention and approach to recruitment
for racial, ethnic and linguistic diverse youth aged 12-17 in the Denver Health catchment
area
Description:
To adapt the Screening and Support for Youth (SASY) intervention and approach to recruitment
for racial, ethnic and linguistic diverse youth aged 12-17 in the Denver Health catchment
area.
Includes the recruitment of 220 youth (170 from schools/community and 50 hard-to-reach).
170 participants will be recruited by QR codes available on flyers that will be distributed
in schools and community settings. This group will then be randomized to either follow up
with the Engaging Youth Expertise for Prevention (EYE) or one of the study team's Research
Coordinators (RC) and either EYE or the RC will carry out the assent/consent process with
youth and their parents/guardians. For the subsequent (non-randomized) group of 50
hard-to-reach participants, the EYE team will utilize various methods for recruitment, and
coordinate the assent/consent process with youth and their parents/guardians.
All 200 participants will be offered a SASY screening which will include the K-CAT, Weiss
Functional Impairment Scale (WFIRS-S), CAT-MH social determinants of health (SDOH), and
assessment of current mental health treatment. All survey instruments will be delivered via
REDCap. Each participant will be assigned a record identification (ID) and an acrostic, so
their data can not be identifiable during analysis. All data will stay within the Cambridge
Health Alliance (CHA) firewall and only the study team will have access to the results. These
products are available in English and Spanish.
A clinical risk score is generated by an algorithm combining symptoms and functional
impairment based on national norms. Tier 1 is within normal, Tier 2 is at clinical risk, and
Tier 3 is clinically ill. All participants will receive a motivational feedback session to
discuss the results of the screening. The discussion will focus on the participant's
reflections on how they feel, their perception of their symptoms and functioning, what
changes they wish to make in their life, and what might support that change. The feedback
will be given to the teens using non-clinical and non-research terms based upon the students'
responses on the screening measures. Tier 1 participants will be offered screening and
feedback on the screening results. Tier 2 participants will be offered screening, feedback on
the screening results and a single session intervention (SSI). Tier 3 participants will be
offered screening, feedback on the screening results, a single session intervention and
information on community resources. The SSI will be accessed by a unique link provided to the
participants, and includes several modules to choose from that participants can complete on
their own and at their own pace.
All participants will be invited for a follow-up survey at 1 month following initial
screening. The follow-up survey will re-assess the KCAT and WFIRS, therapeutic alliance, and
engagement in mental health treatment or behavioral interventions.
All participants will be offered a $20 incentive for the initial screening and $20 for
completing the follow-up survey.